Next, we evaluated the specific effects and mechanisms of moxibustion in modulating the PI3K/AKT/mTOR signaling pathway through lncRNA Six3os1 to provide reliable molecular markers and targets for the clinical diagnosis and treatment of AD. This evidence concerns the gene AKT1 and Alzheimer disease.